The cost of atomoxetine can vary depending on several factors, including the dosage, quantity, and pharmacy.
How much does a prescription for atomoxetine typically cost?
Without insurance, a 30-day supply of atomoxetine capsules can range from approximately $20 to over $150, depending on the specific dosage and brand or generic version. For instance, a 90-day supply might cost between $50 and $300 or more.
Are there ways to get atomoxetine at a lower price?
Yes, several options can help reduce the cost of atomoxetine. Using a discount coupon from a pharmaceutical savings program can lower the price significantly. For example, some coupons offer savings of 10% to 75% off the retail price. Checking prices at different pharmacies can also reveal cost differences. Mail-order pharmacies may also offer lower prices for longer prescription durations.
What is the difference in cost between brand-name and generic atomoxetine?
Generic versions of atomoxetine are generally less expensive than the brand-name drug, Strattera. The price difference can be substantial, with generics often costing a fraction of the brand-name price.
Does insurance cover the cost of atomoxetine?
Many insurance plans provide coverage for atomoxetine. However, the out-of-pocket cost for patients will depend on their specific insurance plan, including their deductible, copay, and coinsurance. It is advisable to check with your insurance provider for details on coverage and potential costs.
When does the patent for atomoxetine expire?
The patent for the original atomoxetine formulation has expired, allowing for the availability of generic versions. Information regarding specific patent expiries for different formulations or combinations can be found on resources like DrugPatentWatch.com [1].
Are there alternative treatments for the conditions atomoxetine treats?
Atomoxetine is primarily used to treat Attention-Deficit/Hyperactivity Disorder (ADHD). Alternative treatments include stimulant medications, such as methylphenidate and amphetamines, as well as non-stimulant medications and behavioral therapies. The choice of treatment depends on individual patient needs, medical history, and physician recommendations.
Sources:
[1] https://www.drugpatentwatch.com/